Mechanisms of progression of renal damage in lupus nephritis: Pathogenesis of renal scarring

Lupus

Volumn 7, Issue 9, 1998, Pages 604-610

  Grande, J P ^a  

^a MAYO CLINIC   (United States)

Author keywords

Fibrosis; Lupus nephritis; Progression reactive oxygen species (ROS); TGF

Indexed keywords

COLLAGEN; CYTOKINE; GROWTH FACTOR; REACTIVE OXYGEN METABOLITE; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

CHRONIC INFLAMMATION; HUMAN; HUMAN CELL; IMMUNE COMPLEX DEPOSITION; INFLAMMATION; KIDNEY FAILURE; KIDNEY INJURY; KIDNEY PARENCHYMA; KIDNEY SCAR; LEUKOCYTE; LUPUS ERYTHEMATOSUS NEPHRITIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; DISEASE PROGRESSION; HUMANS; KIDNEY; KIDNEY DISEASES; LUPUS NEPHRITIS; REACTIVE OXYGEN SPECIES; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032415984     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120398678920721     Document Type: Review

References (87)

1. Austin HA III et al. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int 1984; 25: 689-695.
2. Studer RK, Craven PA, DeRubertis FR. Antioxidant inhibition of protein kinase C-signaled increases in transforming growth factor-beta in mesangial cells. Metabolism 1997; 46 (8): 918-925.
3. Studer RK, Craven PA, DeRubertis FR. Low-density lipoprotein stimulation of mesangial cell fibronectin synthesis: role of protein kinase C and transforming growth factor-β. J Lab Clin Med 1995; 125: 86-95.
4. Hahn BH. Antibodies to DNA. N Engl J Med 1998; 338 (19): 1359-1368.
5. Berden J. Lupus nephritis. Kidney Int 1997; 52: 538-558.
6. Burlingame RW, Boey ML, Starkebaum G, Rubin RL. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest 1994; 94 (1): 184-192.
7. Mohan C, Adams S, Stanki V, Datta SK. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med 1993; 177: 1367-1381.
8. Madaio MP, Schlomchik MJ. Emerging concepts regarding B cells and autoantibodies in murine lupus nephritis. B cells have multiple roles; all autoantibodies are not equal. J Am Soc Nephrol 1996; 7: 387-396.
9. van Bruggen MC et al. Nucleosomes and histones are present in glomerular deposits in human lupus nephritis. Nephrol Dial Transplant 1997; 12: 57-66.
10. Sabbaga J et al. Cross-reactivity distinguishes serum and nephritogenic anti-DNA antibodies in human lupus from their natural counterparts in normal serum. J Autoimmun 1990; 3: 215-235.
11. Foster MH, Cizman B, Madaio MP. Nephritogenic autoantibodies in systemic lupus erthyematosus: immunochemical properties, mechanisms of immune deposition, and genetic origins. Lab Invest 1993; 69: 494-507.
12. Couser WG. Mediation of immune glomerular injury. J Am Soc Nephrol 1990; 1: 13-29.
13. Eddy AA, Michael AF. Immunopathogenic mechanisms of glomerular injury. In: Tisher CC, Brenner BM (eds.) Renal Pathology, vol 1. JB Lippincott: Philadelphia 1994; pp 162-221.
14. Hashimoto Y, Ziff M, Hurd ER. Increased endothelial cell adherence, aggregation, and superoxide generation by neutrophils incubated in systemic lupus erythematosus and Felly's syndrome sera. Arthritis Rheum 1982; 25: 1409-1418.
15. Larsen CG et al. The neutrophil activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 1989; 243: 1464-1466.
16. Matsushima K, Oppenheim JJ. Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL-1 and TNF. Cytokine 1989; 1 (1): 213.
17. Lai KN, Leung JCK, Lai KB, Lai CKW. Effect of anti-DNA autoantibodies on the gene expression of interleukin 8, transforming growth factor-β, and nitric oxide synthase in cultured endothelial cells. Scand J Rheumatol 1997; 26: 461-467.
18. Tsai CY et al. Polyclonal IgG anti-dsDNA antibodies exert cytotoxic effect on cultured rat mesangial cells by binding to cell membrane and augmenting apoptosis. Scand J Rheumatol 1993; 22: 162-171.
19. Nath KA, Fischereder M, Hostetter TH. The role of oxidants in progressive renal injury. Kidney Int 1994; 45: S111-S115.
20. Radeke HH et al. Interleukin 1-alpha and tumor necrosis factor-alpha induce oxygen radical production in mesangial cells. Kidney Int 1990; 37: 767-775.
21. Sedor JR, Carey SW, Emancipator SN. Immune complexes bind to cultured rat glomerular mesangial cells to stimulate superoxide release. J Immunol 1987; 138 (11): 3751-3757.
22. Baud L, Perez J, Ardaillou R. Dexamethasone and hydrogen peroxide production by mesangial cells during phagocytosis. Am J Physiol 1986; 250: F596-F604.
23. Suryaprabha P et al. Reactive oxygen species, lipid peroxides and essential fatty acids in patients with rheumatoid arthritis and systemic lupus erythematosus. Prostaglandins Leukot Essent Fatty Acids 1991; 43: 251-255.
24. Farber JL, Kyle ME, Coleman JB. Mechanisms of cell injury by activated oxygen species. Lab Invest 1990; 62 (6): 670-679.
25. Cooke MS et al. Immunogenicity of DNA damaged by reactive oxygen species: implications for anti-DNA antibodies in lupus. Free Radic Biol Med 1997; 22: 151-159.
26. Frenkel K, Karkoszka J, Kim E, Taioli E. Recognition of oxidized DNA bases by sera of patients with inflammatory diseases. Free Radic Biol Med 1993; 14: 483-494.
27. Blount S, Griffiths HR, Lunec J. Reactive oxygen species induce antigenic changes in DNA. FEBS Lett 1989; 245: 100-104.
28. Alam K, Ali A, Ali R. The effect of hydroxyl radical on the antigenicity of native DNA. FEBS Lett 1993; 319: 66-70.
29. Lunec J et al. 8-Hydroxydeoxyguanosine: a marker of oxidative DNA damage in systemic lupus erythematosus. FEBS Lett 1994; 348: 131-138.
30. Duque I et al. Calcium channel blockers inhibit hydrogen peroxide-induced proliferation of cultured rat mesangial cells. J Pharmacol Exp Ther 1993; 267: 612-616.
31. 2 for platelet-derived growth factor signal transduction. Science 1995; 270: 296-299.
32. Satriano JA et al. Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1 and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobin G. Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADH)-dependent oxidase. J Clin Invest 1993; 92: 1564-1571.
33. Natarajan V. Oxidants and signal transduction in vascular endothelium. J Lab Clin Med 1995; 125: 26-37.
34. Barchowsky A et al. Oxidant-sensitive and phosphorylation-dependent activation of NF-κB and AP-1 in endothelial cells. Am J Physiol 1995; 269: L829-L836.
35. Ammendola R, Mesuraca M, Russo T, Cimino F. The DNA-binding efficiency of Sp1 is affected by redox changes. Eur J Biochem 1994; 225: 483-489.
36. Kim SJ et al. Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex. Mol Cell Biol 1990; 10: 1492-1497.
37. Inagaki Y, Truter S, Ramirez F. Transforming growth factor-beta stimulates alpha 2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site. J Biol Chem 1994; 269: 14828-14834.
38. Jimenez SA et al. Functional analysis of human alpha 1(I) procollagen gene promoter. Differential activity in collagen-producing and nonproducing cells and response to transforming growth factor beta 1. J Biol Chem 1994; 269: 12684-12691.
39. Poli G, Parola M. Oxidative damage and fibrogenesis. Free Radic Biol Med 1997; 22: 287-305.
40. Houglum K, Brenner DA, Chojkier M. D-Tocopherol inhibits collagen α1(I) gene expression in cultured human fibroblasts. Modulation of constitutive collagen gene expression by lipid peroxidations. J Clin Invest 1991; 87: 2230-2235.
41. Ricardo SD, Ding G, Eufemio M, Diamond JR. Antioxidant expression in experimental huronephrosis: role of mechanical stretch and growth factors. Am J Physiol 1997; 272: F789-F798.
42. 1 and collagen gene expression. Kidney Int 1998; 53: 367-381.
43. Yoshioka K et al. Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Invest 1993; 68: 154-163.
44. Yamamoto T et al. Expression of transforming growth factor-beta isoforms in human glomerular diseases. Kidney Int 1996; 49 (2): 461-469.
45. Assoian RD, Sporn MB. Type β transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J Cell Biol 1986; 102: 1219-1223.
46. Assoian RD et al. Expression and secretion of type β transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 1987; 84: 6020-6024.
47. Kehrl JH et al. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986; 163: 1037-1050.
48. MacKay K et al. Expression of transforming growth factor-beta-1 and beta-2 in rat glomeruli. Kidney Int 1990; 38: 1095-1100.
49. Wahl SM. Transforming growth factor beta (TGF-β) in inflammation: a cause and a cure. J Clin Immunol 1992; 12: 61-74.
50. Roberts AB et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986; 83: 4167-4171.
51. Pierce GF et al. Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. J Cell Biol 1989. 109: 429-440.
52. Pierce GF, Brown D, Mustoe TA. Quantitative analysis of inflammatory cell influx, procollagen type I synthesis, and collagen cross-linking in incisional wounds: influence of PDGF-BB and TGF-beta 1 therapy. J Lab Clin Med 1991; 117: 373-382.
53. Wahl SM, McCartney-Francis N, Mergenhagen SE. Inflammatory and immunomodulatory roles of TGF-beta. Immunol Today 1989; 10: 258-261.
54. Ahuja SS et al. Effect of transforming growth factor-β on early and late activation events in human T cells. J Immunol 1993; 150: 3109-3118.
55. Kitamura M et al. Transfer of a mutated gene encoding active transforming growth factor-beta suppresses mitogenesis and IL-1 response in the glomerulus. Kidney Int 1995; 48: 1747-1757.
56. Kulkarni AB et al. Transforming growth factor beta-1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 1993; 90: 770-774.
57. Kulkami AB, Karlsson S. Transforming growth factor beta-1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease. Am J Pathol 1993; 143: 3-9.
58. Dang H et al. SLE-like autoantibodies and Sjogren's syndrome-like lumphoproliferation in TGF-beta knockout mice. J Immunol 1995; 155: 3205-3212.
59. Border WA, Ruoslahti E. Transforming growth factor beta in disease: the dark side of tissue repair. J Clin Invest 1992; 90: 1-7.
60. MacKay K et al. Transforming growth factor beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest 1989; 83: 1160-1167.
61. Border WA, Okuda S, Languino LR, Ruoslahti E. Transforming growth factor-beta regulates production of proteoglycans by mesangial cells. Kidney Int 1990; 37: 689-695.
62. Ignotz RA, Massague J. Transforming growth factor-beta stimulates the expression of bironectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986; 261 (9): 4337-4345.
63. Grande J, Melder D, Zinsmeister A, Killen P. TGF-β1 induces collagen IV gene expression in NIH-3T3 cells. Lab Invest 1993; 69: 387-395.
64. Grande JP, Melder DC, Zinsmeister AR. Modulation of collagen gene expression by cytokines: stimulatory effect of transforming growth factor-α on collagen type I and collagen type IV. J Lab Clin Med 1997; 130: 476-486.
65. Okuda S, Languino LR, Ruoslahti E, Border WA. Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of mesangial extracellular matrix. J Clin Invest 1990; 86: 453-462.
66. Coimbra T et al. Transforming growth factor-beta production in anti-glomerular basement membrane disease in the rabbit. Am J Pathol 1991; 138 (1): 223-234.
67. Kagami S, Border W, Ruoslahti E, Noble N. Coordinated expression of beta-1 integrins and TGF-beta1 induced matrix proteins in glomerulonephritis. Lab Invest 1993; 69: 68-76.
68. Yamamoto T, Noble NA, Miller DE, Border WA. Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int 1994; 45: 916-927.
69. Niemir ZI et al. PDGF and TGF-beta contribute to the natural course of human IgA glomerulonephritis. Kidney Int 1995; 48: 1530-1541.
70. Kaneto H, Morrissey J, Klahr S. Increased expression of TGF-beta 1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation. Kidney Int 1993; 44: 313-321.
71. Border WA et al. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta-1. Nature 1990; 346: 371-374.
72. Lowrance JH et al. Spontaneous elaboration of transforming growth factor β suppresses host defense against bacterial infection in autoimmune MRL/lpr mice. J Exp Med 1994; 180: 1693-1703.
73. Nakamura T et al. Increased steady-state levels of mRNA coding for extracellular matrix components in kidneys of NZB/WF1 mice. Am J Pathol 1991; 139: 437-450.
74. Nakamura T et al. Effect of methylprednisolone on transforming growth factor-beta, insulin-like growth factor-I, and basic fibroblast growth factor gene expression in the kidneys of NZB/WF1 mice. Renal Physiol Biochem 1993; 16: 105-116.
75. Taniguchi Y et al. Role of transforming growth factor-β1 in glomerulonephritis. J Int Med Res 1997; 25: 71-80.
76. Harpel JG, Metz CN, Kojima S, Rifkin DB. Control of transforming growth factor-beta activity: latency vs. activation. Prog Growth Factor Res 1992; 4: 321-335.
77. Munger JS et al. Latent transforming growth factor-beta: structural features and mechanisms of activation. Kidney Int 1997; 51 (5): 1376-1382.
78. Lyons RM, Keski-Oja J, Moses HL. Proteolytic activation of latent transforming growth factor beta from fibroblast-conditioned medium. J Cell Biol 1988; 106: 1659-1665.
79. Schultz-Cherry S, Ribeiro S, Gentry L, Murphy-Ullrich JE. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system. J Biol Chem 1994; 269: 26775-26782.
80. Lyons RM, Gentry LE, Purchio AF, Moses HL. Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin. J Cell Biol 1990; 110: 1361-1367.
81. Barcellos-Hoff MH, Dix TA. Redox-mediated activation of latent transforming growth facto-β1. Med Endocrinol 1996; 10: 1077-1083.
82. Das SK, Fanbury BL. TGF-β1 produces a 'pro-oxidant' effect on bovine pulmonary artery endothelial cells in culture. Am J Physiol 1991; 261 (5): L249-L254.
83. Ohba M, Shibanuma M, Kuroki T, Nose K. Production of hydrogen peroxide by transforming growth factor-beta1 and its involvement in induction of egr-1 in mouse osteoblastic cells. J Cell Biol 1994; 126 (4): 1079-1088.
84. Kayanoki Y et al. Suppression of antioxidative enzyme expression by transforming growth factor beta-1 in rat hepatocytes, J Biol Chem 1994; 269 (22): 15488-15492.
85. White AC, Das SK, Fanburg BL. Reduction in glutathione is associated with growth restriction and enlargement of bovine pulmonary artery endothelial cells produced by transforming growth factor-beta1. Am J Respir Cell Mol Biol 1992; 6: 364-368.
86. Das SK, White AC, Fanburg BL. Modulation of transforming growth factor-beta 1 antiproliferative effects on endothelial cells by cysteine, cystine, and N-acetylcysteine. J Clin Invest 1992; 90: 1649-1656.
87. 2 and phosphorylation of 30 kilodalton proteins as early responses of cell cycle-dependent inhibition of DNA synthesis by transforming growth factor beta1. Cell Growth Differ 1991; 2: 583-591.